Area of research
Endocrinology, Diabetes and Metabolism · Pharmacology
Research interest
Research interests include Diabetes Treatment and Management, Pharmacology and Obesity Treatment, Diabetes, Cardiovascular Risks, and Lipoproteins, and Diet and metabolism studies.
Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials
Management and impact of obesity in Canada: A real-world survey of people with obesity and their physicians
Therapeutic inertia in obesity management among people living with obesity from the perspective of general/family practitioners in Canada: A mixed-methods study.
Management and impact of obesity in Canada: A real-world survey of people with obesity and their physicians.
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
Cost-effectiveness of weight-management pharmacotherapies in Canada: a societal perspective.
Prevalence of Adult Type 2 Diabetes Mellitus and Related Complications in Alberta, Canada: A Retrospective, Observational Study Using Administrative Data.
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Obesity in adults: a clinical practice guideline
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study
2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
The Obesity Epidemic and Its Impact on Hypertension